BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21128826)

  • 41. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal activity of Apulia region propolis.
    Cafarchia C; De Laurentis N; Milillo MA; Losacco V; Puccini V
    Parassitologia; 1999 Dec; 41(4):587-90. PubMed ID: 10870567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
    Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
    Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Seifert H; Aurbach U; Stefanik D; Cornely O
    Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemical composition and antifungal potential of Brazilian propolis against Candida spp.
    Freires IA; Queiroz VCPP; Furletti VF; Ikegaki M; de Alencar SM; Duarte MCT; Rosalen PL
    J Mycol Med; 2016 Jun; 26(2):122-132. PubMed ID: 26916845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antifungal Effects of
    Moghim H; Taghipour S; Kheiri S; Khabbazi H; Baradaran A
    Int J Prev Med; 2021; 12():163. PubMed ID: 35070196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal and anti-biofilm activity of a new Spanish extract of propolis against Candida glabrata.
    Fernández-Calderón MC; Hernández-González L; Gómez-Navia C; Blanco-Blanco MT; Sánchez-Silos R; Lucio L; Pérez-Giraldo C
    BMC Complement Med Ther; 2021 May; 21(1):147. PubMed ID: 34020643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Ethiopian multiflora honey on fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients.
    Mulu A; Diro E; Tekleselassie H; Belyhun Y; Anagaw B; Alemayehu M; Gelaw A; Biadglegne F; Desalegn K; Yifiru S; Tiruneh M; Kassu A; Nishikawa T; Isogai E
    Int J STD AIDS; 2010 Nov; 21(11):741-5. PubMed ID: 21187354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Structure, biological properties of honey, pollen and royal jelly and their possible use in nutrition therapy].
    Dubtsova EA
    Eksp Klin Gastroenterol; 2009; (3):36-41. PubMed ID: 19928000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp.
    Alburquenque C; Bucarey SA; Neira-Carrillo A; Urzúa B; Hermosilla G; Tapia CV
    Med Mycol; 2010 Dec; 48(8):1018-23. PubMed ID: 20482450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients.
    Hadley S; Martinez JA; McDermott L; Rapino B; Snydman DR
    J Antimicrob Chemother; 2002 Feb; 49(2):415-9. PubMed ID: 11815592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].
    Lee MK; Yong D; Kim M; Kim MN; Lee K
    Korean J Lab Med; 2010 Aug; 30(4):364-72. PubMed ID: 20805708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.